AU2001260083A1 - New pharmaceutical composition and the process for its preparation - Google Patents

New pharmaceutical composition and the process for its preparation

Info

Publication number
AU2001260083A1
AU2001260083A1 AU2001260083A AU6008301A AU2001260083A1 AU 2001260083 A1 AU2001260083 A1 AU 2001260083A1 AU 2001260083 A AU2001260083 A AU 2001260083A AU 6008301 A AU6008301 A AU 6008301A AU 2001260083 A1 AU2001260083 A1 AU 2001260083A1
Authority
AU
Australia
Prior art keywords
preparation
pharmaceutical composition
new pharmaceutical
new
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260083A
Inventor
Thyge Borup Hjorth
Helle Weibel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Dr Reddys Research Foundation
Original Assignee
Novo Nordisk AS
Dr Reddys Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2000/000291 external-priority patent/WO2001091751A1/en
Application filed by Novo Nordisk AS, Dr Reddys Research Foundation filed Critical Novo Nordisk AS
Publication of AU2001260083A1 publication Critical patent/AU2001260083A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
AU2001260083A 2000-05-26 2001-05-21 New pharmaceutical composition and the process for its preparation Abandoned AU2001260083A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US57888700A 2000-05-26 2000-05-26
US09578887 2000-05-26
US20777700P 2000-05-30 2000-05-30
US60207777 2000-05-30
WODK00/00291 2000-05-30
PCT/DK2000/000291 WO2001091751A1 (en) 2000-05-30 2000-05-30 New pharmaceutical composition and the process for its preparation
PCT/DK2001/000348 WO2001089523A1 (en) 2000-05-26 2001-05-21 New pharmaceutical composition and the process for its preparation

Publications (1)

Publication Number Publication Date
AU2001260083A1 true AU2001260083A1 (en) 2001-12-03

Family

ID=27222180

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260083A Abandoned AU2001260083A1 (en) 2000-05-26 2001-05-21 New pharmaceutical composition and the process for its preparation

Country Status (5)

Country Link
US (2) US6710050B2 (en)
EP (1) EP1303273A1 (en)
JP (1) JP2004506609A (en)
AU (1) AU2001260083A1 (en)
WO (1) WO2001089523A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915835A (en) * 1998-12-01 2001-08-21 Novo Nordisk As Pharmaceutical composition, and, process for the preparation of a composition
CA2858422C (en) * 2011-12-09 2020-01-07 Merck Patent Gmbh Anhydrous sodium carbonate having a low pore content
EP3344274A4 (en) 2015-09-01 2019-05-22 First Wave Bio, Inc. Methods and compositions for treating conditions associated with an abnormal inflammatory responses
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698788B1 (en) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Effervescent pharmaceutical composition containing ibuprofen and process for its preparation.
ATE227122T1 (en) * 1993-09-03 2002-11-15 Smithkline Beecham Corp STABILIZED TABLET FORMULATION
DK0800384T3 (en) * 1994-12-14 2001-04-17 Enbalt Trading Ltd Pharmaceutical tablet formulations for direct compression
CZ292256B6 (en) * 1995-05-05 2003-08-13 Novo Nordisk A/S Pharmaceutical mixture and process for preparing thereof
DE69723869T2 (en) * 1996-12-31 2004-04-22 Dr. Reddy's Laboratories Ltd. HETEROCYCLIC COMPOUNDS, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEIR AND THEIR APPLICATION IN THE TREATMENT OF DIABETIS AND RELATED DISEASES
EP0945134A1 (en) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG New galenic formulations of meloxicam for oral administration
BR9915835A (en) * 1998-12-01 2001-08-21 Novo Nordisk As Pharmaceutical composition, and, process for the preparation of a composition

Also Published As

Publication number Publication date
JP2004506609A (en) 2004-03-04
US20020010187A1 (en) 2002-01-24
WO2001089523A1 (en) 2001-11-29
EP1303273A1 (en) 2003-04-23
US20040091523A1 (en) 2004-05-13
US6710050B2 (en) 2004-03-23

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2001250420A1 (en) Pharmaceutical compositions
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2001274307A1 (en) Pharmaceutical compositions
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
AU1887401A (en) Medicinal composition
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
AU5565099A (en) Pharmaceutical compositions and methods for use
AU2001290239A1 (en) Medicinal composition
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001273919A1 (en) Pharmaceutical compositions
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU4085201A (en) Pharmaceutical composition
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
HUP0104544A3 (en) New pharmaceutical composition and the process for its preparation
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation